BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28168665)

  • 1. The Life Cycle of Engineered Nanoparticles.
    González-Gálvez D; Janer G; Vilar G; Vílchez A; Vázquez-Campos S
    Adv Exp Med Biol; 2017; 947():41-69. PubMed ID: 28168665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the occupational, consumer and environmental exposure to engineered nanomaterials used in 10 technology sectors.
    Nowack B; Brouwer C; Geertsma RE; Heugens EH; Ross BL; Toufektsian MC; Wijnhoven SW; Aitken RJ
    Nanotoxicology; 2013 Sep; 7(6):1152-6. PubMed ID: 22783888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling the risks of nano-enabled products through the life cycle: The case of nano copper oxide paint for wood protection and nano-pigments used in the automotive industry.
    Semenzin E; Subramanian V; Pizzol L; Zabeo A; Fransman W; Oksel C; Hristozov D; Marcomini A
    Environ Int; 2019 Oct; 131():104901. PubMed ID: 31279910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology in agriculture: Opportunities, toxicological implications, and occupational risks.
    Iavicoli I; Leso V; Beezhold DH; Shvedova AA
    Toxicol Appl Pharmacol; 2017 Aug; 329():96-111. PubMed ID: 28554660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Human Exposure to ENMs.
    Jiménez AS; van Tongeren M
    Adv Exp Med Biol; 2017; 947():27-40. PubMed ID: 28168664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Dose to Response: In Vivo Nanoparticle Processing and Potential Toxicity.
    Graham UM; Jacobs G; Yokel RA; Davis BH; Dozier AK; Birch ME; Tseng MT; Oberdörster G; Elder A; DeLouise L
    Adv Exp Med Biol; 2017; 947():71-100. PubMed ID: 28168666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MARINA Risk Assessment Strategy: A Flexible Strategy for Efficient Information Collection and Risk Assessment of Nanomaterials.
    Bos PM; Gottardo S; Scott-Fordsmand JJ; van Tongeren M; Semenzin E; Fernandes TF; Hristozov D; Hund-Rinke K; Hunt N; Irfan MA; Landsiedel R; Peijnenburg WJ; Sánchez Jiménez A; van Kesteren PC; Oomen AG
    Int J Environ Res Public Health; 2015 Nov; 12(12):15007-21. PubMed ID: 26633430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward the development of decision supporting tools that can be used for safe production and use of nanomaterials.
    Som C; Nowack B; Krug HF; Wick P
    Acc Chem Res; 2013 Mar; 46(3):863-72. PubMed ID: 23110540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact and effectiveness of risk mitigation strategies on the insurability of nanomaterial production: evidences from industrial case studies.
    Bergamaschi E; Murphy F; Poland CA; Mullins M; Costa AL; McAlea E; Tran L; Tofail SA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):839-55. PubMed ID: 25808636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace.
    Engeman CD; Baumgartner L; Carr BM; Fish AM; Meyerhofer JD; Satterfield TA; Holden PA; Harthorn BH
    J Occup Environ Hyg; 2013; 10(9):487-95. PubMed ID: 23927041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental and health effects of nanomaterials in nanotextiles and façade coatings.
    Som C; Wick P; Krug H; Nowack B
    Environ Int; 2011 Aug; 37(6):1131-42. PubMed ID: 21397331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key principles and operational practices for improved nanotechnology environmental exposure assessment.
    Svendsen C; Walker LA; Matzke M; Lahive E; Harrison S; Crossley A; Park B; Lofts S; Lynch I; Vázquez-Campos S; Kaegi R; Gogos A; Asbach C; Cornelis G; von der Kammer F; van den Brink NW; Mays C; Spurgeon DJ
    Nat Nanotechnol; 2020 Sep; 15(9):731-742. PubMed ID: 32807878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of nanomaterial aging and transformations through the life cycle of nano-enhanced products.
    Mitrano DM; Motellier S; Clavaguera S; Nowack B
    Environ Int; 2015 Apr; 77():132-47. PubMed ID: 25705000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on Conventional and Advanced Methods for Nanotoxicology Evaluation of Engineered Nanomaterials.
    Leudjo Taka A; Tata CM; Klink MJ; Mbianda XY; Mtunzi FM; Naidoo EB
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nanotechnologies: prediction of the possible negative effect of insoluble nanoparticles on the body].
    Velichkovskiĭ BT
    Gig Sanit; 2011; (2):75-8. PubMed ID: 21604397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nanotechnology and food safety].
    De Ariño Otxoa A
    Nutr Hosp; 2018 Jun; 35(Spec No4):146-149. PubMed ID: 30070138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer exposures to laser printer-emitted engineered nanoparticles: A case study of life-cycle implications from nano-enabled products.
    Pirela SV; Sotiriou GA; Bello D; Shafer M; Bunker KL; Castranova V; Thomas T; Demokritou P
    Nanotoxicology; 2015; 9(6):760-8. PubMed ID: 25387251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New sector of employment--a review of data on nanoproduction, research and development in the field of nanotechnology in Poland].
    Popławska M; Mikołajczyk U; Bujak-Pietrek S
    Med Pr; 2015; 66(4):575-82. PubMed ID: 26536974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of Engineered Nanomaterials in Nano-Enabled Products Exhibiting Priority Environmental Exposure.
    Lehutso RF; Tancu Y; Maity A; Thwala M
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33806400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.